enGene Holdings Inc. Cash Flow Statement

Cash Flow Statement Oct2022 Oct2023 Oct2024
Operating Activities
Net Income -24.46M-99.92M-55.14M
Depreciation and Depletion 0.24M0.17M0.32M
Share-based Compensation 0.12M3.45M5.32M
Gains from Investment Securities 3.33M-10.85M1.90M
Cash from Operations -17.59M-24.74M-48.30M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.80M-0.23M
Depreciation & Amortization (CF) 0.20M0.20M0.30M
Change in Working Capital
Change in Account Payables -0.20M0.37M0.47M
Change in Accured Expenses 2.34M0.87M5.22M
Other Working Capital Changes 0.11M0.75M7.57M
Investing Activities
Capital Expenditures 0.15M0.32M0.93M
Cash from Investing Activities -0.15M-0.32M-125.95M
Financing Activities
Other financing activities 0.39M0.58M
Cash from Financing Activities 27.97M86.15M265.72M
Additional items
Exchange Rate Effect -0.81M0.00M0.00M
Change in Cash 9.42M61.09M91.48M
Free Cash Flow -17.75M-25.06M-49.23M
Net Cash Flow 10.22M61.09M91.46M